Skip to main content
🚚 Free Shipping|Free shipping on orders over $150.00|Lab Tested • Avg. Purity 99%+
Triple agonist GIP/GLP-1/Glucagon
Next-generation triple agonist peptide.
1 Unit
Base Price
$162.00
3-5 Units
Save 10%
$145.80
$162.00
6-9 Units
Save 15%
$137.70
$162.00
10+ Units
⭐ Best ValueSave 20%
$129.60
$162.00
💡 Volume discounts available for bulk orders
RESEARCH USE ONLY: FOR RESEARCH USE ONLY: This product is intended for laboratory and research purposes only. Not for human or animal consumption. By purchasing, you confirm this product will be used exclusively for legitimate research.
Next-generation triple agonist peptide.
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This innovative approach aims to maximize metabolic benefits through activation of three complementary pathways.
Key Research Areas:
• Maximum weight loss potential
• Enhanced glucagon-mediated lipolysis
• Improved glucose homeostasis
• Energy expenditure increase
• Metabolic disease treatment
Early clinical data suggests retatrutide may produce the most significant weight loss of any incretin-based therapy studied to date.
RESEARCH USE ONLY: All products sold on this website are intended for laboratory and research purposes only. These products are NOT intended for human or animal consumption.
